Burning Rock Biotech (BNR) Free Cash Flow: 2019-2025
Historic Free Cash Flow for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $2.3 million.
- Burning Rock Biotech's Free Cash Flow rose 114.52% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.5 million, marking a year-over-year decrease of 1749.64%. This contributed to the annual value of -$13.4 million for FY2024, which is 63.99% up from last year.
- As of Q3 2025, Burning Rock Biotech's Free Cash Flow stood at $2.3 million, which was up 103.39% from -$67.9 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Free Cash Flow ranged from a high of $19.1 million in Q1 2024 and a low of -$239.8 million during Q3 2023.
- In the last 3 years, Burning Rock Biotech's Free Cash Flow had a median value of -$15.9 million in 2024 and averaged -$38.8 million.
- As far as peak fluctuations go, Burning Rock Biotech's Free Cash Flow slumped by 1,632.50% in 2021, and later spiked by 215.74% in 2024.
- Over the past 5 years, Burning Rock Biotech's Free Cash Flow (Quarterly) stood at -$17.6 million in 2021, then spiked by 46.00% to -$9.5 million in 2022, then skyrocketed by 76.30% to -$2.3 million in 2023, then spiked by 215.74% to $2.6 million in 2024, then spiked by 114.52% to $2.3 million in 2025.
- Its last three reported values are $2.3 million in Q3 2025, -$67.9 million for Q2 2025, and -$23.5 million during Q1 2025.